Trademark: PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
Mark Identification
PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
Proof of use for PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
We do not have any records of a proof of use for PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE at this moment.
Click here to add a proof of use for PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
Possible trademark infringements of PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
Basic Information about PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE
- Serial Number
- 87021803
- Filing Date
- 02 May 2016
- Registration Number
- 5104363
- Registration Date
- 20 Dec 2016
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE on the blockchain with WikiTrademarks.io.
- First use of PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE anywhere
- PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE was first used on 31 Oct 2015 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE?
1. American Association for Cancer Research, Inc. Philadelphia PA
2. American Association for Cancer Research, Inc. Philadelphia PA
3. American Association for Cancer Research, Inc. Philadelphia PA
Correspondent
- MARK A. STEINER,
- DUANE MORRIS LLP
- SPEAR TWR
- 1 MARKET PLZ STE 2200
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on PROJECT GENIE GENOMICS EVIDENCE NEOPLASIA INFORMATION EXCHANGE